Video Experimental Relacionado
Updated: Aug 6, 2026
10:03
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Efectos del probucol en la remodelación vascular después de la angioplastia coronaria. Multivitaminas y Protocolo
G Côté1, J C Tardif, J Lespérance
1Department of Medicine, Montreal Heart Institute, Montreal, Canada.
Circulation
|January 13, 1999
Resumen
Probucol mejora la remodelación vascular después de la angioplastia con globo, reduciendo la restenosis. Este estudio utilizó ultrasonido intravascular (IVUS) para demostrar el probucol.
Área de la Ciencia:
- Medicina Cardiovascular La medicina cardiovascular es una especialidad de la salud.
- Cardiología Intervencionista Cardiología intervencionista.
- Farmacología Farmacología.
Sus antecedentes:
- Estudios previos indicaron que el probucol reduce la restenosis después de la angioplastia.
- La angiografía fue insuficiente para determinar si el probucol prevenía la formación de neointimales o mejoraba la remodelación vascular.
- La ecografía intravascular (IVUS) fue necesaria para diferenciar estos efectos.
Objetivo del estudio:
- Investigar el mecanismo por el cual el probucol reduce la restenosis después de la angioplastia con globo.
- Para determinar si el efecto del probucol se debe a la prevención de la formación de neointimales o la mejora de la remodelación vascular.
- Para utilizar IVUS para el análisis detallado de los cambios vasculares.
Principales métodos:
- Un ensayo aleatorizado en el que participaron 317 pacientes sometidos a angioplastia con globo.
- Los pacientes recibieron probucol, multivitaminas, tratamiento combinado o placebo durante 6 meses después de la angioplastia.
- La ecografía intravascular (IVUS) se realizó inmediatamente después de la angioplastia y en el seguimiento en 94 pacientes.
Principales resultados:
- El área luminal disminuyó en el grupo placebo, con cambios que se correlacionan más con el área de la membrana elástica externa (EME) que con el área de la pared.
- Probucol solo mostró una reducción significativa en la pérdida de lumen (-0,15 mm2) en comparación con el placebo (-1,21 mm2).
- El tratamiento con probucol condujo a un aumento significativo en el área EEM (1,74 mm2), lo que indica una mejor remodelación vascular.
Conclusiones:
- La pérdida de lúmen después de la angioplastia es el resultado de una remodelación vascular inadecuada en respuesta a la formación neointimal.
- Probucol mejora efectivamente la remodelación vascular, ejerciendo así sus efectos antirretenóticos.
- El análisis IVUS confirmó el impacto beneficioso del probucol en los mecanismos de remodelación vascular.
Más Videos Relacionados
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
05:25Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
Videos de Conceptos Relacionados
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...